USPTO serial 88854341
NOUREXAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 13, 2024
- Examiner
- MEYERS, MORGAN LAURA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NOUREXAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica Connarn
Jessica Connarn SINORICA LLC DBA THOUGHTS TO PAPER20251 CENTURY BLVD STE 140GERMANTOWN, MD 20874UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-inflammatories; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, injectables and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular prevention preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, injectables and pharmaceutical preparations for the prevention of cardiovascular disorders; Pharmaceutical preparations and substances for the treatment of aging and aging-related diseases, as well as viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, Alzheimer, gastrointestinal, hormonal, dermatological, psychiatric, mental depression and immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention of ischemia-dependent aging and aging-related diseases, including musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, Alzheimer, hormonal, dermatological, psychiatric, mental depression and immune system related diseases and disorders; Neurological Pharmaceuticals; Neurological treatment preparations; Musculoskeletal Pharmaceuticals; Vascular Pharmaceuticals; Pharmaceuticals for Prevention of Ischemic Injury; Pharmaceuticals for Prevention of Disease Progression; Cellular Energy Preservation Pharmaceuticals | ACTIVE | Aug 2, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 13, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 13, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 6, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 5, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 12, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 11, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 1, 2023 | IUAF | USE AMENDMENT FILED | — |
| Dec 1, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 29, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 29, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 29, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 14, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 1, 2023 | PBSR | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | — |
| Jul 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 27, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 17, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 29, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 17, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 17, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 29, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 29, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 29, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2020 | NWAP | NEW APPLICATION ENTERED | — |